Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients WithRASWild-Type Advanced Colorectal Cancer

Journal article published in 2016 by Jenny F. Seligmann, Faye Elliott, Susan D. Richman, Bart Jacobs, Gemma Hemmings, Sarah Brown, Jennifer H. Barrett, Sabine Tejpar, Philip Quirke

, Matthew T. Seymour

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving forbidden

Policy details

Data provided by